Enjoy complimentary customisation on priority with our Enterprise License!
The global pupillometer market size is estimated to grow by USD 167.46 million at a CAGR of 7.28% between 2023 and 2028.
Advanced sensors and optical systems have improved the precision of pupillometers in measuring pupil size and reactivity. This exactness is essential for precise neurological and ophthalmological assessments. Modern pupillometers often come with software that allows for real-time data analysis and documentation. This feature simplifies the assessment process and provides healthcare providers with valuable data for patient records. Furthermore, advanced pupillometers offer multi-modal assessments, combining various technologies such as infrared imaging, pupillary light response, and dynamic pupillometry for a comprehensive evaluation. Hence, the technological advancements in pupillometer will boost the growth of the market during the forecast period.
Technavio has segmented the market into Product, Type, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The market share growth by the tabletop segment will be significant during the forecast period. Various market players, such as Johnson and Johnson and Haag Streit Group, offer table-top pupillometers. The growing number of neurological disorders will drive the demand for tabletop pupillometers during the next five years since pupillometers are used to detect the curvature of the eye in neurological defects, such as cerebral insult.
Get a glance at the market contribution of various segments Download PDF Sample
The tabletop segment was valued at USD 184.60 million in 2017. Furthermore, researchers in many fields, which include anesthesiology and pain, have been using pupillometry to measure the functioning of the autonomic nervous system, measure the metabolism of drugs, detect drug impairment and fatigue, and many other applications in both humans and animals. Consequently, the applications of pupillometers will drive the growth of the tabletop segment and, in turn, boost the growth of the global pupillometer market during the forecast period.
Video pupillometers provide objective and highly quantitative measurements of pupil size and reactivity. Video pupillometry is a non-invasive method that does not require physical contact with the eye. This minimizes patient discomfort and reduces the risk of cross-contamination. Video pupillometers can provide real-time monitoring of pupillary changes, which is particularly important in critical care settings. Moreover, video pupillometers can be used to remotely monitor patients pupillary responses, providing valuable data for healthcare providers even from a distance. Thus, the benefits of the video pupillometer will promote the growth of the video segment and strengthen the growth of the global pupillometer market during the forecast period.
Digital pupillometers provide objective and highly quantitative measurements of pupil size and reactivity. Digital pupillometers offer high levels of accuracy and precision in measuring pupil size and responses to various stimuli, such as light. This accuracy is crucial in clinical assessments and research. Moreover, digital pupillometers are commonly used in clinical research and clinical trials. In addition, digital pupillometers offer advanced features such as dynamic tracking, which allows continuous monitoring of pupillary responses and automated analysis, which can save time and improve efficiency. Thus, these factors will drive the growth of the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The US and Canada accounted for the largest market shares in the region in the same year. The growth of the regional market can be attributed to the advanced healthcare infrastructure in the region, the strong market presence of leading market players, the rising prevalence of neurological diseases, and growing R&D activities and clinical studies on neuro therapies and systems in the region.
Furthermore, the North American region has a significant prevalence of neurological conditions, including traumatic brain injuries (TBI), strokes, and neurodegenerative diseases. Moreover, the growing prevalence of neurological diseases across the region is a major driving factor for the growth of the market. Thus, the high rate of neurological disorders propels the demand for pupillometers in this region, which is expected to spur the growth of the market during the forecast period.
The outbreak of COVID-19 in 2020 had a negative impact on the growth of the pupillometer market in North America. However, in 2021, the initiation of large-scale vaccination drives?lifted the lockdown and travel restrictions, which led to the resumption of manufacturing facilities in the region. Furthermore, the percentage of adults reporting that they needed but did not receive mental health counseling or therapy increased from 9.2% to 11.7% during the same period. Therefore, the rise in mental health disorders provided the opportunity for regional market players to offer pupillometers for the treatment of neuropsychiatric disorders, which is anticipated to drive the growth of the regional market during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Adaptica Srl: .The company offers pupillometer such as 2WIN which is a mobile and binocular vision screener that measures both eyes at the same time, in real life vision conditions.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The rising prevalence of neurological disorders is the key factor driving market growth. Pupillometers provide healthcare professionals with a non-invasive and objective way to assess changes in pupil size and reactivity, aiding in the early detection of neurological abnormalities. Pupillometers play an important role in assessing stroke patients, helping healthcare providers determine the type of stroke and its impact on the patient neurological status.
Moreover, pupillometers enable standardized assessments of pupillary responses. This standardization is important in research, clinical trials, and clinical practice, allowing for consistent and comparable measurements across patients. Hence, the rising prevalence of neurological disorders will strengthen the growth of the market in focus during the forecast period.
Increasing number of awareness initiatives and improvements in access to healthcare is the primary trend shaping market growth. Several public and private organizations are taking initiatives to promote awareness and improve access to healthcare for patients with neurological disorders. WHO works with partners and stakeholders to improve access to healthcare for people with epilepsy. Brain Awareness Week (BAW), which is organized by the Dana Alliance for Brain Initiatives, is a global campaign that aims to improve public awareness about the progress and benefits of brain research.
Moreover, the International Neuromodulation Society (INS) is a non-profit organization (NPO) that is dedicated to the scientific development of neuromodulation. It also educates and promotes neuromodulation through meetings, peer-reviewed journals, explanatory content, and chapter websites. Hence, the increasing number of awareness initiatives and improvements in access to healthcare will drive the growth of the global pupillometer market during the forecast period.
Lack of awareness about pupillometers is a challenge that affects market growth. Healthcare professionals may not be aware of the existence, capabilities, and benefits of pupillometers, leading to limited adoption. Consequently, patients may not receive the full spectrum of care that pupillometers can provide. Lack of awareness can result in missed opportunities for early diagnosis and intervention. Healthcare facilities and practices that are unaware of the value of pupillometers may underutilize these devices or continue to rely on traditional assessment methods, even when more advanced and objective assessments are available.
Furthermore, a lack of awareness can lead to diagnostic delays, particularly in cases where pupillometers could provide critical information for the timely diagnosis of neurological and ophthalmological conditions. Even when pupillometers are available in healthcare facilities, healthcare professionals may not use them consistently or correctly if they are not fully aware of their benefits and applications. Hence, such factors will impede the growth of the market in focus during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Pupillometer Market Customer Landscape
The pupillometer market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
Pupillometer Market Scope |
|
Report Coverage |
Details |
Page number |
158 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.28% |
Market Growth 2024-2028 |
USD 167.46 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
6.85 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 35% |
Key countries |
US, Germany, UK, Japan, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Adaptica Srl, AMETEK Inc., Bernell Corp., EssilorLuxottica, Grobet USA, HAAG-STREIT DEUTSCHLAND GmbH, Hansraj Nayyar Medical India Pvt. Ltd., Hilco Vision, IDMED, iVIS Technologies S.r.l., Johnson and Johnson, Konan Medical USA Inc., Lombart Instrument Inc., NeurOptics Inc., NIDEK Co. Ltd., Rexxam Co. Ltd., TOPCON CORP., US Ophthalmic LLC, Vigor Optical, and Visionix |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.